September 26, 2007 - Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging ...
September 26, 2007 - Rcadia Medical Imaging Ltd., developer of novel computer-aided diagnostic software, has received a ...
Penn Presbyterian Medical Center, a University of Pennsylvania Health System hospital, is rated one of the top 100 Top Hospitals for cardiovascular care by Solucient — a distinction it has received for five consecutive years. Located in Philadelphia, the 350-bed facility has a long history of providing products and procedures that improve patient care.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 25, 2007 - Cordis Corp. today announced the introduction in the U.S. market of the FIRE STAR Rx PTCA ...
September 25, 2007 - The risk of developing venous thromboembolism while flying on an airplane, a condition known as “economy class syndrome,” is only about one in 5,000 for long flights, although the odds of in-flight clot are higher for some groups, according to a new study out of The Netherlands.
September 25, 2007 - Abbott Laboratories said it is working with the FDA Administration to schedule an advisory panel ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The FIRE STAR Rx PTCA Dilatation Catheter and the DURA STAR Rx PTCA Dilatation Catheter are indicated for expansion in the narrowed area of a coronary artery or bypass graft. The FIRE STAR Balloon features the lowest pre-dilatation profile in the market.
September 25, 2007 - The Sorin Group, a European cardiovascular company, announced today that it has received FDA ...
September 25, 2007 - Abbott enrolled the first patient in HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 25, 2007 – ScottCare Corp., a noninvasive external counterpulsation (ECP) therapy and cardiopulmonary ...
September 25, 2007 - The Medicines Company announced that the FDA has accepted its supplemental new drug application (sNDA) for a modified dosing regimen of Angiomax (bivalirudin) for the treatment of acute coronary syndromes (ACS), specifically in patients with unstable angina or non-segment elevation myocardial infarction (NSTEMI), which could replace heparin in patients undergoing angioplasty.
September 24, 2007 - Stentys announced that its drug-eluting bifurcated stent for treatment of blocked coronary artery ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 21, 2007-The CYPHER Sirolimus-eluting Coronary Stent reduced by more than half the rate of major adverse ...
September 21, 2007 - Catheter angiography may be unnecessary in cases where the CT angiogram (CTA) is indeterminate for ...
September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy approved to reduce mortality and morbidity in the CABG patient population.